Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 9

Results: 14

A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4 and CD8 T-cell as well as B-cell responses.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1333, doi. 10.1007/s00262-011-1030-6

By:

Neumann, Frank;
Kubuschok, Boris;
Ertan, Kubilay;
Schormann, Claudia;
Stevanovic, Stefan;
Preuss, Klaus-Dieter;
Schmidt, Werner;
Pfreundschuh, Michael

Publication type:

Article

Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1227, doi. 10.1007/s00262-011-1020-8

By:

Gameiro, Sofia;
Caballero, Jorge;
Higgins, Jack;
Apelian, David;
Hodge, James

Publication type:

Article

Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1243, doi. 10.1007/s00262-011-1024-4

By:

Yan, Mengyong;
Himoudi, Nourredine;
Basu, B.;
Wallace, Rebecca;
Poon, Edmund;
Adams, Stuart;
Hasan, Fyeza;
Xue, Shao-An;
Wilson, Natalie;
Dalgleish, Angus;
Williams, Owen;
Anderson, John

Publication type:

Article

Immunotherapy eradicates metastases with reversible defects in MHC class I expression.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1257, doi. 10.1007/s00262-011-1027-1

By:

Garrido, Cristina;
Romero, Irene;
Berruguilla, Enrique;
Cancela, Bárbara;
Algarra, Ignacio;
Collado, Antonia;
García-Lora, Angel;
Garrido, Federico

Publication type:

Article

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1299, doi. 10.1007/s00262-011-1037-z

By:

Bao, Lei;
Dunham, Kimberly;
Lucas, Kenneth

Publication type:

Article

Obituary: Joseph Lustgarten, 1963-2011.

Published in:

2011

By:

Ostrand-Rosenberg, Suzanne;
Celis, Esteban;
Cohen, Peter;
Eshher, Zelig;
Gendler, Sandra;
Hoelzinger, Dominique;
Hurwitz, Arthur;
Pease, Larry;
Sherman, Linda

Publication type:

Obituary

Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4 and CD8 T cells.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1281, doi. 10.1007/s00262-011-1034-2

By:

Guenterberg, Kristan;
Lesinski, Gregory;
Mundy-Bosse, Bethany;
Karpa, Volodymyr;
Jaime-Ramirez, Alena;
Wei, Lai;
Carson, William

Publication type:

Article

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4 T cells from patients with GI malignancy.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1269, doi. 10.1007/s00262-011-1029-z

By:

Mundy-Bosse, Bethany;
Young, Gregory;
Bauer, Todd;
Binkley, Elaine;
Bloomston, Mark;
Bill, Matthew;
Bekaii-Saab, Tanios;
Carson, William;
Lesinski, Gregory

Publication type:

Article

Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1347, doi. 10.1007/s00262-011-1035-1

By:

Foureau, David;
McKillop, Iain;
Jones, Chase;
Amin, Asim;
White, Richard;
Salo, Jonathan

Publication type:

Article

Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1289, doi. 10.1007/s00262-011-1033-3

By:

Takahara, Akitaka;
Koido, Shigeo;
Ito, Masaki;
Nagasaki, Eijiro;
Sagawa, Yukiko;
Iwamoto, Takeo;
Komita, Hideo;
Ochi, Toshiki;
Fujiwara, Hiroshi;
Yasukawa, Masaki;
Mineno, Junichi;
Shiku, Hiroshi;
Nishida, Sumiyuki;
Sugiyama, Haruo;
Tajiri, Hisao;
Homma, Sadamu

Publication type:

Article

Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1309, doi. 10.1007/s00262-011-1038-y

By:

Geary, S.;
Lemke, C.;
Lubaroff, D.;
Salem, A.

Publication type:

Article

CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1319, doi. 10.1007/s00262-011-1032-4

By:

Myers, Cheryl;
Hanavan, Paul;
Antwi, Kwasi;
Mahadevan, Daruka;
Nadeem, A.;
Cooke, Laurence;
Scheck, Adrienne;
Laughrey, Zachary;
Lake, Douglas

Publication type:

Article

Lung cancer and Toll-like receptors.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1211, doi. 10.1007/s00262-011-1057-8

By:

Pinto, Aldo;
Morello, Silvana;
Sorrentino, Rosalinda

Publication type:

Article

Therapeutic effects of metformin in breast cancer: involvement of the immune system?

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1221, doi. 10.1007/s00262-011-1062-y

By:

Schott, Sarah;
Bierhaus, Angelika;
Schuetz, Florian;
Beckhove, Philipp;
Schneeweiss, Andreas;
Sohn, Christof;
Domschke, Christoph

Publication type:

Article